Who Owns FibroBiologics Stock?
NASDAQ: FBLGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:37 AM ET
Ownership breakdown
- Held by institutions
- 14.87%
- Held by insiders
- 13.74%
- Institutional holders
- 19
- Institutions 14.9%
- Insiders 13.7%
- Public and other 71.4%
Who owns FibroBiologics stock?
Institutional investors own about 14.9% of FibroBiologics's shares, spread across 19 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 13.74% of FBLG.
The largest institutional holders are Cascade Financial Partners, LLC (1.63%), Fund Evaluation Group, LLC (0.78%) and Geode Capital Management, LLC (0.46%). Together, the top 10 institutions control 4.3% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their FBLG positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FBLG
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Cascade Financial Partners, LLC | 108.83K | 1.63% | +562.5% |
| Fund Evaluation Group, LLC | 51.79K | 0.78% | 0.0% |
| Geode Capital Management, LLC | 30.30K | 0.46% | +2.3% |
| Vanguard Capital Management LLC | 27.77K | 0.42% | -59.0% |
| Qube Research & Technologies Ltd | 24.31K | 0.37% | +100.0% |
| Blackrock Inc. | 18.24K | 0.27% | -26.0% |
| Barclays Plc | 7.24K | 0.11% | +100.0% |
| Vanguard Fiduciary Trust Co | 6.38K | 0.10% | 0.0% |
| Tower Research Capital LLC (TRC) | 4.73K | 0.07% | +927.8% |
| Osaic Holdings Inc. | 2.40K | 0.04% | +1461.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FBLG
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 27.77K | 0.42% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 24.38K | 0.37% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.57K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.27K | 0.03% |
Frequently asked questions
Who is the largest shareholder of FibroBiologics?
Cascade Financial Partners, LLC is the largest institutional shareholder of FBLG, owning 1.63% of shares outstanding (108.83K shares) as of its latest 13F filing.
What percentage of FibroBiologics is owned by institutions?
Institutions own about 14.9% of FBLG shares and 17.2% of the public float.
How much of FibroBiologics do insiders own?
Insiders, such as officers and directors, own about 13.74% of FBLG shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.